.Common-Size Income Statement
Difficulty: Beginner
AbbVie Inc., Common-Size Consolidated Income Statement
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| | Net revenues | ||||||||||
| | Cost of products sold | ||||||||||
| | Gross margin | % | | % | | % | | % | | % | |
| | Selling, general and administrative | ||||||||||
| | Research and development | ||||||||||
| | Acquired in-process research and development | ||||||||||
| | Other expense | ||||||||||
| | Operating earnings | % | | % | | % | | % | | % | |
| | Interest expense | ||||||||||
| | Interest income | ||||||||||
| | Interest expense, net | % | | % | | % | | % | | % | |
| | Net foreign exchange loss | ||||||||||
| | Other income (expense), net | ||||||||||
| | Earnings before income tax expense | % | | % | | % | | % | | % | |
| | Income tax expense | ||||||||||
| | Net earnings | % | | % | | % | | % | | % | |
